Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00230893 · ClinicalTrials.gov registry record
Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years
A clinical trial, sponsored by Tuscaloosa Research & Education Advancement Corporation.
- Completed
- Registry status
- 99
- Enrollment target
NCT00230893 is a clinical trial that has completed, run by Tuscaloosa Research & Education Advancement Corporation. The registered enrollment target is 99 participants.
The verdict
NCT00230893 has completed, sponsored by Tuscaloosa Research & Education Advancement Corporation.
- COMPLETED
- Registry status
- 99 participants
- Enrollment target
Study Summary
The primary objective is to examine the percentage of patients with PTSD who were prescribed an antipsychotic over the past seven years in the VA Network 7 (AL, GA, SC) and compare the percentage on an annual basis. We will also determine the type and dose of antipsychotics received. We hypothesize that there has been a significant increase in antipsychotic use, especially atypical antipsychotics, prescribed for patients with PTSD over the last 7 years
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2005-07 |
| Est. Completion | 2005-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00230893
The ClinicalTrials.gov registry entry for NCT00230893 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tuscaloosa Research & Education Advancement Corporation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00230893 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00230893 about?
NCT00230893 is a clinical study titled "Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years". The primary objective is to examine the percentage of patients with PTSD who were prescribed an antipsychotic over the past seven years in the VA Network 7 (AL, GA, SC) and compare the percentage on an annual basis. We will also determine the type and dose of antipsychotics received. We hypothesize ...
What is the current status of trial NCT00230893?
This trial is currently completed. The enrollment target is 99 participants. The study started on 2005-07. Estimated completion is 2005-09.
Who is sponsoring clinical trial NCT00230893?
This trial is sponsored by Tuscaloosa Research & Education Advancement Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.